PPTS Portal Home

Revised 2022 (Resolution 24)

Document Navigator

Document Navigator

ACR–ASNR–SPR PRACTICE PARAMETER FOR THE PERFORMANCE OF INTRACRANIAL MAGNETIC RESONANCE PERFUSION IMAGING

PREAMBLE

I.

INTRODUCTION

II.

INDICATIONS

II.

INDICATIONS

A.

Assessment of Neurovascular Disease

II.

INDICATIONS

B.

Diagnosis and Characterization of Mass Lesions

II.

INDICATIONS

C.

Neurological Disorders Involving Alterations of the Brain Perfusion, in the Appropriate Clinical Setting

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

IV.

SPECIFICATIONS OF THE EXAMINATION

A.

Physician

IV.

SPECIFICATIONS OF THE EXAMINATION

B.

Facility Requirements

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

1.

Dynamic susceptibility contrast MRI (DSC MRI) T2* perfusion (also known as bolus-tracking MRI)

a.

Technique

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

1.

Dynamic susceptibility contrast MRI (DSC MRI) T2* perfusion (also known as bolus-tracking MRI)

b.

Data Processing

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

1.

Dynamic susceptibility contrast MRI (DSC MRI) T2* perfusion (also known as bolus-tracking MRI)

c.

Interpretation

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

2.

DCE MRI, also known as “permeability” MRI – T1 permeability mapping

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

3.

ASL perfusion MRI

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

3.

ASL perfusion MRI

a.

Technique

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

3.

ASL perfusion MRI

b.

Data Processing

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

4.

Advantages, disadvantages, and comparison of MR perfusion techniques

IV.

SPECIFICATIONS OF THE EXAMINATION

C.

Examination Technique

5.

Perfusion imaging in pediatric

V.

DOCUMENTATION

VI.

EQUIPMENT SPECIFICATIONS

VII.

SAFETY GUIDELINES

VIII.

QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION

ACKNOWLEDGEMENTS

REFERENCES

1. Alvarez-Linera J. 3T MRI: advances in brain imaging. Eur J Radiol. 2008 Sep;67(3):415-26.
2. Essig M, Nguyen TB, Shiroishi MS, et al. Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol. 2013 Sep;201(3):W495-510.
3. Essig M, Shiroishi MS, Nguyen TB, et al. Perfusion MRI: the five most frequently asked technical questions. AJR Am J Roentgenol. 2013 Jan;200(1):24-34.
4. Luypaert R, Boujraf S, Sourbron S, Osteaux M. Diffusion and perfusion MRI: basic physics. Eur J Radiol. 2001 Apr;38(1):19-27.
5. Paldino MJ, Barboriak DP. Fundamentals of quantitative dynamic contrast-enhanced MR imaging. Magn Reson Imaging Clin N Am. 2009 May;17(2):277-89.
6. Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol. 2000 Jul;175(1):207-19.
7. Schaefer PW, Barak ER, Kamalian S, et al. Quantitative assessment of core/penumbra mismatch in acute stroke: CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged. Stroke. 2008 Nov;39(11):2986-92.
8. Speck O, Chang L, DeSilva NM, Ernst T. Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques. J Magn Reson Imaging. 2000 Sep;12(3):381-7.
9. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke. 2002 Apr;33(4):1146-51.
10. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003 May;17(5):509-20.
11. Golay X, Guenther M. Arterial spin labelling: final steps to make it a clinical reality. Magma. 25(2):79-82, 2012 Apr.
12. Wolf RL, Detre JA. Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging. Neurotherapeutics. 2007 Jul;4(3):346-59.
13. Jahng GH, Li KL, Ostergaard L, Calamante F. Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques. Korean J Radiol. 2014;15(5):554-77.
14. Kim HJ, Kim TW, Ryu SY, et al. Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography. Clin Imaging. 35(6):413-20, 2011 Nov-Dec.
15. Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am. 1999 May;9(2):309-31.
16. Ma J, Mehrkens JH, Holtmannspoetter M, et al. Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99mTc-ECD SPECT. Neuroradiology 2007;49:317-26.
17. Wang DJ, Alger JR, Qiao JX, et al. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke. 2012 Apr;43(4):1018-24.
18. Hu LS, Eschbacher JM, Heiserman JE, et al. Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro-oncol. 14(7):919-30, 2012 Jul.
19. Korfiatis P, Erickson B. The basics of diffusion and perfusion imaging in brain tumors. Appl Radiol. 2014 Jul;43(7):22-29.
20. Lacerda S, Law M. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am. 2009 Nov;19(4):527-57.
21. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24(10):1989-98.
22. Warmuth C, Gunther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology. 2003 Aug;228(2):523-32.
23. Cobb-Pitstick KM, Munjal N, Safier R, Cummings DD, Zuccoli G. Time Course of Cerebral Perfusion Changes in Children with Migraine with Aura Mimicking Stroke. AJNR Am J Neuroradiol. 2018 Sep;39(9):1751-1755.
24. Du AT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology. 2006 Oct 10;67(7):1215-20.
25. Floery D, Vosko MR, Fellner FA, et al. Acute-onset migrainous aura mimicking acute stroke: MR perfusion imaging features. Ajnr: American Journal of Neuroradiology. 33(8):1546-52, 2012 Sep.
26. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005 Mar;234(3):851-9.
27. Kim SM, Kim MJ, Rhee HY, et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology. 2013 Jan;55(1):25-34.
28. Théberge J. Perfusion magnetic resonance imaging in psychiatry. Top Magn Reson Imaging. 2008 Apr;19(2):111-30.
29. Ye FQ, Smith AM, Mattay VS, et al. Quantitation of regional cerebral blood flow increases in prefrontal cortex during a working memory task: a steady-state arterial spin-tagging study. Neuroimage. 1998 Jul;8(1):44-9.
30. Ye FQ, Smith AM, Yang Y, et al. Quantitation of regional cerebral blood flow increases during motor activation: a steady-state arterial spin tagging study. Neuroimage. 1997 Aug;6(2):104-12.
31. American College of Radiology. ACR Practice Parameter for Performing and Interpreting Magnetic Resonance Imaging (MRI). Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=146+&releaseId=2
32. American College of Radiology. ACR–SPR Practice Parameter for the use of Intravascular Contrast Media. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=142+&releaseId=2
33. American College of Radiology. ACR Committee on Drugs and Contrast Media. Manual on Contrast Media. Available at: https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Contrast-Manual.
34. American College of Radiology. ACR–SIR Practice Parameter For Minimal and/or Moderate Sedation/Analgesia. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=95+&releaseId=2
35. Ata ES, Turgut M, Eraslan C, Dayanir YÖ. Comparison between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labeling techniques in distinguishing malignant from benign brain tumors. Eur J Radiol. 2016 Sep;85(9):S0720-048X(16)30167-X.
36. Cha S, Lu S, Johnson G, Knopp EA. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging. 2000 Feb;11(2):114-9.
37. Chappell MA, Okell TW, Jezzard P, Woolrich MW. A general framework for the analysis of vessel encoded arterial spin labeling for vascular territory mapping. Magn Reson Med. 2010 Nov;64(5):1529-39.
38. Dallery F, Bouzerar R, Michel D, et al. Perfusion magnetic resonance imaging in pediatric brain tumors. Neuroradiology. 2017 Nov;59(11):1143-1153.
39. Gaudino S, Martucci M, Botto A, et al. Brain DSC MR Perfusion in Children: A Clinical Feasibility Study Using Different Technical Standards of Contrast Administration. AJNR Am J Neuroradiol. 2019 Feb;40(2):359-365.
40. Giesel FL, Mehndiratta A, Risse F, et al. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla. Acta Radiol. 2009 Jun;50(5):521-30.
41. Haller S, Rodriguez C, Moser D, et al. Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: a BOLD and perfusion MRI study. Neuroscience. 2013 Oct 10;250():S0306-4522(13)00603-9.
42. Hartkamp NS, van Osch MJ, Kappelle J, Bokkers RP. Arterial spin labeling magnetic resonance perfusion imaging in cerebral ischemia. [Review]. Current Opinion in Neurology. 27(1):42-53, 2014 Feb.Curr Opin Neurol. 27(1):42-53, 2014 Feb.
43. Helle M, Rüfer S, Alfke K, Jansen O, Norris DG. Perfusion territory imaging of intracranial branching arteries - optimization of continuous artery-selective spin labeling (CASSL). NMR Biomed. 2011 May;24(4):404-12.
44. Liang X, Tournier JD, Masterton R, et al. A k-space sharing 3D GRASE pseudocontinuous ASL method for whole-brain resting-state functional connectivity. Int J Imaging Syst Technol 2012;22:37-43.
45. Manka C, Träber F, Gieseke J, Schild HH, Kuhl CK. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose. Radiology. 2005 Mar;234(3):869-77.
46. Østergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging. 2005 Dec;22(6):710-7.
47. Paiva FF, Tannús A, Talagala SL, Silva AC. Arterial spin labeling of cerebral perfusion territories using a separate labeling coil. J Magn Reson Imaging. 2008 May;27(5):970-7.
48. Schmiedeskamp H, Andre JB, Straka M, et al. Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. J Cereb Blood Flow Metab. 2013 May;33(5):732-43.
49. Sorensen AG. Perfusion MR imaging: moving forward. Radiology. 2008 Nov;249(2):416-7.
50. Talagala SL, Ye FQ, Ledden PJ, Chesnick S. Whole-brain 3D perfusion MRI at 3.0 T using CASL with a separate labeling coil. Magn Reson Med. 2004 Jul;52(1):131-40.
51. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991 Feb;17(2):357-67.
52. Wang Z, Wang J, Connick TJ, Wetmore GS, Detre JA. Continuous ASL (CASL) perfusion MRI with an array coil and parallel imaging at 3T. Magn Reson Med. 2005 Sep;54(3):732-7.
53. Wong EC. Vessel-encoded arterial spin-labeling using pseudocontinuous tagging. Magn Reson Med. 2007 Dec;58(6):1086-91.
54. Schmiedeskamp H, Straka M, Newbould RD, et al. Combined spin- and gradient-echo perfusion-weighted imaging. Magn Reson Med. 2012 Jul;68(1):30-40.
55. Kovar DA, Lewis M, Karczmar GS. A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging. 1998;8(5):1126-34.
56. Parker G, Padhani AR. T1-W DCE MRI: T1-weighted dynamic contrast-enhanced MRI. In: Tofts PS, ed. Quantitative MRI of the brain: measuring changes caused by disease. Chichester, West Sussex, England: John Wiley & Sons; 2003:341-64.
57. Yang C, Karczmar GS, Medved M, Oto A, Zamora M, Stadler WM. Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis. Magn Reson Med. 2009 Apr;61(4):851-9.
58. Yang C, Karczmar GS, Medved M, Stadler WM. Estimating the arterial input function using two reference tissues in dynamic contrast-enhanced MRI studies: fundamental concepts and simulations. Magn Reson Med. 2004 Nov;52(5):1110-7.
59. Yankeelov TE, Luci JJ, Lepage M, et al. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging. 2005 May;23(4):519-29.
60. Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. [Review]. Magn Reson Med. 73(1):102-16, 2015 Jan.
61. Forkert ND, Li MD, Lober RM, Yeom KW. Gray Matter Growth Is Accompanied by Increasing Blood Flow and Decreasing Apparent Diffusion Coefficient during Childhood. AJNR Am J Neuroradiol. 2016 Sep;37(9):1738-44.
62. Harreld JH, Helton KJ, Kaddoum RN, et al. The effects of propofol on cerebral perfusion MRI in children. Neuroradiology. 2013 Aug;55(8):1049-1056.
63. Huisman TA, Sorensen AG. Perfusion-weighted magnetic resonance imaging of the brain: techniques and application in children. Eur Radiol. 2004 Jan;14(1):59-72.
64. Narayanan S, Schmithorst V, Panigrahy A. Arterial Spin Labeling in Pediatric Neuroimaging. Semin Pediatr Neurol. 2020 Apr;33():S1071-9091(20)30005-X.
65. American College of Radiology. ACR Practice Parameter for Communication of Diagnostic Imaging Findings. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=74+&releaseId=2
66. American College of Radiology. ACR–AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of Magnetic Resonance (MR) Imaging Equipment. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=57+&releaseId=2
67. American College of Radiology. ACR Committee on MR Safety. 2024 ACR Manual on MR Safety. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Radiology-Safety/Manual-on-MR-Safety.pdf.